© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, BlossomHill Therapeutics, Inc. (BLSM) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into BLSM's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
BlossomHill Therapeutics, Inc. (BLSM) technical indicators as of September 20, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess BLSM's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
BlossomHill Therapeutics, Inc. (BLSM) stock performance overview as of September 20, 2026: The 52-week high is $27.8 (currently N/A below), and the 52-week low is $15.6 (currently N/A above). Over the past year, BLSM's performance is N/A, compared to the S&P 500's 0.41% change.
| 52-Week High | 27.8 |
| 52-Week High Chg | - |
| 52-Week Low | 15.6 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 0.41% |
According to market data, BlossomHill Therapeutics, Inc. (BLSM) stock's recent performance metrics show that over the last month, BLSM is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize BLSM's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 27.8 | 27.8 | 27.8 | 27.8 | 27.8 | 27.8 |
| Low | 20.45 | 15.6 | 15.6 | 15.6 | 15.6 | 15.6 |
| Performance | - | - | - | - | - | - |
According to current financial data, BLSM stock's P/E (TTM) ratio is -23.83, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for BLSM, including P/S (N/A), P/B (-4.92), and P/FCF (-23.15), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BLSM | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -23.83 | -1.25 | -194.38 | 32.59 |
| P/S (TTM) | N/A | 3.76 | 467.58 | 5.98 |
| P/B (TTM) | -4.92 | 1.34 | 16.06 | 5.99 |
| P/FCF (TTM) | -23.15 | -1.71 | -689.78 | 30.77 |